ARCHIVES

Group Chairs Urge NCI to Limit Authority of Steering Committees That Determine Which Trials Get Funded

This article is from The Cancer Letter archive.

Vol. 37 No. 31 | August 5, 2011

Download PDF Visit The Full Archive

Related Articles

FDA Says ImClone Data Insufficient To Evaluate Colorectal Cancer Drug C225.

January 4, 2002

DeVita Says NCAB Subcommittee’s Recommendation For Reshaping Organ Site Program Is “Reasonable”

April 23, 1982

ASCO Urges Increase In Research Funding, Removal of Barriers For Trial Participation

January 23, 2009

1978, ’79 budget Projections By Research Programs

November 25, 1977

Virus Program Changes reviews Subcommittee Report Set Fro June

November 23, 1974

Women’s Health Trial Not Dead; Pls Say They’ll Improve Protocol, Make New Plans For Full Implementation

January 29, 1988